EVOLVING REGULATORY POLICIES FOR ORPHAN DRUGS POST-COVID-19: UK AND INDIAN PERSPECTIVES
Crossref DOI link: https://doi.org/10.30574/wjbphs.2026.27.3.0467
Published Online: 2026-09-30
Update policy: https://doi.org/10.30574/wjbphs.ourcrossmarkpolicy
Muneshwa, Rohit
Navghare, Vijay
Jadhav, Suryakant
Gaikwad, Uday
